Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study

BACKGROUND: This study aimed to comprehensively explore the occurrence and risk factors for adverse events (AEs) and adverse drug reactions (ADRs) (especially for thrombocytopenia and bleeding) in Chinese patients with high bleeding risk (older adults, or complicated with diabetes mellitus or renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Xiaoping, Li, Zhenyong, Li, Dunheng, Li, Zhongyin, Lu, Zhaohua, Luo, Caidong, Ji, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166107/
https://www.ncbi.nlm.nih.gov/pubmed/37168321
http://dx.doi.org/10.3389/fcvm.2022.821322

Ejemplares similares

Ejemplares similares